Kevin Wasko

428 total citations
11 papers, 70 citations indexed

About

Kevin Wasko is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kevin Wasko has authored 11 papers receiving a total of 70 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Immunology. Recurrent topics in Kevin Wasko's work include CRISPR and Genetic Engineering (10 papers), CAR-T cell therapy research (5 papers) and Pluripotent Stem Cells Research (3 papers). Kevin Wasko is often cited by papers focused on CRISPR and Genetic Engineering (10 papers), CAR-T cell therapy research (5 papers) and Pluripotent Stem Cells Research (3 papers). Kevin Wasko collaborates with scholars based in United States. Kevin Wasko's co-authors include Jennifer A. Doudna, Connor A. Tsuchida, Jennifer Hamilton, Kai‐Hsin Chang, Kate Zhang, Mark S. Shearman, Charles F. Albright, Georgia Giannoukos, Wayne Ngo and Alanna Schepartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

In The Last Decade

Kevin Wasko

10 papers receiving 69 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Wasko United States 5 48 16 16 14 3 11 70
Galen Xing United States 2 38 0.8× 17 1.1× 9 0.6× 12 0.9× 2 50
Yan Yi Chen United States 2 35 0.7× 17 1.1× 8 0.5× 12 0.9× 2 46
Jennifer R. Fang United States 2 71 1.5× 11 0.7× 26 1.6× 22 1.6× 1 0.3× 2 96
Malte Thodberg Denmark 5 71 1.5× 17 1.1× 7 0.4× 11 0.8× 3 1.0× 6 98
Netravathi Krishnappa United States 2 79 1.6× 23 1.4× 9 0.6× 23 1.6× 3 90
Patricia Lorden Spain 3 78 1.6× 18 1.1× 5 0.3× 15 1.1× 2 0.7× 3 118
Sarah Offley United States 5 108 2.3× 8 0.5× 9 0.6× 14 1.0× 3 1.0× 6 123
Allen Thayakumar India 5 30 0.6× 12 0.8× 8 0.5× 11 0.8× 5 68
Wunna Kyaw Australia 5 31 0.6× 6 0.4× 22 1.4× 6 0.4× 2 0.7× 6 64
Yangcan Chen China 6 101 2.1× 13 0.8× 5 0.3× 21 1.5× 2 0.7× 9 116

Countries citing papers authored by Kevin Wasko

Since Specialization
Citations

This map shows the geographic impact of Kevin Wasko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Wasko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Wasko more than expected).

Fields of papers citing papers by Kevin Wasko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Wasko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Wasko. The network helps show where Kevin Wasko may publish in the future.

Co-authorship network of co-authors of Kevin Wasko

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Wasko. A scholar is included among the top collaborators of Kevin Wasko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Wasko. Kevin Wasko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ngo, Wayne, et al.. (2026). Targeted delivery of genome editors in vivo. Nature Biotechnology. 44(1). 49–59.
2.
Ma, Enbo, Kai Chen, Honglue Shi, et al.. (2025). Directed evolution expands CRISPR–Cas12a genome-editing capacity. Nucleic Acids Research. 53(13). 1 indexed citations
3.
Wasko, Kevin, et al.. (2025). Packaged delivery of CRISPR–Cas9 ribonucleoproteins accelerates genome editing. Nucleic Acids Research. 53(5). 9 indexed citations
4.
Shi, Honglue, Kevin Wasko, Marena Trinidad, et al.. (2025). Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing. Molecular Cell. 85(9). 1730–1742.e9. 3 indexed citations
5.
Shi, Honglue, Kevin Wasko, Marena Trinidad, et al.. (2025). BPS2025 - Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing. Biophysical Journal. 124(3). 90a–90a. 1 indexed citations
6.
Tsuchida, Connor A., Kevin Wasko, Jennifer Hamilton, & Jennifer A. Doudna. (2024). Targeted nonviral delivery of genome editors in vivo. Proceedings of the National Academy of Sciences. 121(11). 29 indexed citations
7.
Wasko, Kevin, et al.. (2021). Deletion of CISH and TGFβR2 in iPSC-Derived NK Cells Promotes High Cytotoxicity and Enhances In Vivo Tumor Killing. Blood. 138(Supplement 1). 2780–2780. 10 indexed citations
8.
Allen, Alexander G., Kevin Wasko, John A. Zuris, et al.. (2021). A Bicistronic Vector Expressing CD16 and a Membrane Bound IL-15 Construct in iPSC Derived NK Cells Increased Cytotoxicity and Persistence. Blood. 138(Supplement 1). 4809–4809. 4 indexed citations
10.
Moon, Jung-Il, Kevin Wasko, Karrie Wong, et al.. (2020). Generation of Natural Killer Cells with Enhanced Function from a CRISPR/Cas12a-Edited Induced Pluripotent Stem Cell Line. Blood. 136(Supplement 1). 8–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026